C-reactive protein and Procalcitonin levels in Prostate Cancer.


Ilktac A. , Kalkan S., Çalışkan S.

International journal of clinical practice, vol.75, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75
  • Publication Date: 2021
  • Doi Number: 10.1111/ijcp.13935
  • Title of Journal : International journal of clinical practice

Abstract

Aim Prostate cancer (PCa) is one of the most common cancers among men in the world. Prostate-specific antigen is the most used biomarker for PCa diagnosis. In this study, we aimed to measure the procalcitonin (PCT) and C-reactive protein (CRP) levels in patients with PCa.